iBio, Inc. (IBIO)
1.42
-0.01
(-0.70%)
USD |
NASDAQ |
Aug 24, 16:00
1.40
-0.02
(-1.41%)
After-Hours: 20:00
iBio Total Assets (Quarterly) : 85.83M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 85.83M |
| December 31, 2025 | 64.39M |
| September 30, 2025 | 64.16M |
| June 30, 2025 | 23.18M |
| March 31, 2025 | 19.10M |
| December 31, 2024 | 21.70M |
| September 30, 2024 | 24.52M |
| June 30, 2024 | 28.73M |
| March 31, 2024 | 50.15M |
| December 31, 2023 | 34.02M |
| September 30, 2023 | 37.68M |
| June 30, 2023 | 41.21M |
| March 31, 2023 | 44.39M |
| December 31, 2022 | 51.80M |
| September 30, 2022 | 84.56M |
| June 30, 2022 | 99.41M |
| March 31, 2022 | 115.37M |
| December 31, 2021 | 126.45M |
| September 30, 2021 | 143.74M |
| June 30, 2021 | 146.97M |
| March 31, 2021 | 142.70M |
| December 31, 2020 | 145.41M |
| September 30, 2020 | 117.25M |
| June 30, 2020 | 94.19M |
| March 31, 2020 | 42.22M |
| Date | Value |
|---|---|
| December 31, 2019 | 36.38M |
| September 30, 2019 | 35.16M |
| June 30, 2019 | 30.59M |
| March 31, 2019 | 35.67M |
| December 31, 2018 | 40.30M |
| September 30, 2018 | 42.90M |
| June 30, 2018 | 43.08M |
| March 31, 2018 | 31.03M |
| December 31, 2017 | 34.84M |
| September 30, 2017 | 33.43M |
| June 30, 2017 | 36.01M |
| March 31, 2017 | 40.70M |
| December 31, 2016 | 44.19M |
| September 30, 2016 | 48.09M |
| June 30, 2016 | 51.60M |
| March 31, 2016 | 50.66M |
| December 31, 2015 | 9.416M |
| September 30, 2015 | 11.37M |
| June 30, 2015 | 12.49M |
| March 31, 2015 | 11.45M |
| December 31, 2014 | 11.04M |
| September 30, 2014 | 6.657M |
| June 30, 2014 | 6.494M |
| March 31, 2014 | 8.214M |
| December 31, 2013 | 9.618M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Capricor Therapeutics, Inc. | 368.74M |
| Ocugen, Inc. | 124.21M |
| CytomX Therapeutics, Inc. | 381.23M |
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 8.297M |
| Shareholders Equity (Quarterly) | 77.54M |
| Debt to Equity Ratio | 0.03 |
| Current Ratio | 11.88 |
| Net Debt Paydown Yield | 0.56% |